1-(5-Carboxypentyl)-2-(5-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfo-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl)-3,3-dimethyl-5-sulfo-3H-indolium hydroxide, inner salt
|
813-237-7
|
146368-10-7
|
|
Notified C&L
|
View details
|
Acid brown 432:1
|
943-953-6
|
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,1,3-trimethyl-2H-benzo[e]-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1,3-trimethyl-1H-benzo[e]indolium tetraphenylborate
|
813-238-2
|
402475-23-4
|
|
Notified C&L
|
View details
|
AGELAS Stade 13
|
943-954-1
|
|
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
Carc. 2
|
Notified C&L
|
View details
|
AKOR082
|
|
|
|
Notified C&L
|
View details
|
Bis-(4-tert.-butyl-phenyl)-iodonium bistrifluoromethanesulfonimidate
|
813-240-3
|
460731-32-2
|
|
Notified C&L
|
View details
|
AKOR083
|
|
|
|
Notified C&L
|
View details
|
2-Fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide
|
813-241-9
|
1029712-80-8
|
Acute Tox. 2
Repr. 1B
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
4-(4-(2-(7-(Diethylamino)-2-oxo-2H-chromen-3-yl)vinyl)quinolinium-1-yl)butane-1-sulfonate
|
943-959-9
|
|
|
Notified C&L
|
View details
|
4-(4-(2-(7-(Diethylamino)-2-oxo-2H-chromen-3-yl)vinyl)pyridinium-1-yl)butane-1-sulfonate
|
943-960-4
|
|
|
Notified C&L
|
View details
|
AKOR084
|
|
|
|
Notified C&L
|
View details
|
Reaction mass of octyl dihydrogen phosphate and decyl dihydrogen phosphate and dioctyl hydrogen phosphate and didecyl hydrogen phosphate and decyl octyl hydrogen phosphate
|
943-963-0
|
|
|
Notified C&L
|
View details
|
2-bromo-1-(4-octylphenyl)ethanone
|
813-242-4
|
64068-76-4
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2-[2-(2-Diphenylamino-3-[2-[3-(2-acetoxy-ethyl)-1,1-dimethyl-7-sulfo-1,3-dihydro-benzo[e]indol-2-ylidene]-ethylidene]-cyclopent-1-enyl)-vinyl]-3-(2-acetoxy-ethyl)-1,1-dimethyl-7-sulfo-1H-benzo[e]indolium hydroxide, inner salt
|
943-965-1
|
|
Eye Irrit. 2
Aquatic Acute 1
|
Notified C&L
|
View details
|
1-(2-Methoxy-ethyl)-2-[2-(3-[2-[1-(2-methoxy-ethyl)-3,3-dimethyl-1,3-dihydro-indol-2-ylidene]-ethylidene]-2-phenylsulfanyl-cyclohex-1-enyl)-vinyl]-3,3-dimethyl-3H-indolium tetraphenylborate
|
943-966-7
|
|
|
Notified C&L
|
View details
|
3-Butyl-5-(2-(2-(3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium-2-yl)vinyl)-6-(2-(3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)indolin-2-ylidene)ethylidene)cyclohex-1-en-1-yl)-1-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate, tetrasodium salt
|
943-967-2
|
|
|
Notified C&L
|
View details
|
2-[5-[1-(5-Carboxypentyl)-3,3-dimethyl-5-sulfo-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, disodium salt
|
943-968-8
|
|
|
Notified C&L
|
View details
|
2-[2-(2-Chloro-3-[2-[1,1-dimethyl-7-sulfo-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-ethylidene]-cyclopent-1-enyl)-vinyl]-1,1-dimethyl-7-sulfo-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, triethylammonium salt
|
943-969-3
|
|
|
Notified C&L
|
View details
|
3-(1,3-dioxopropan-2-yl)-2-nitrobenzoic acid
|
813-244-5
|
205680-83-7
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
CI-FIGM-11
|
813-269-1
|
51326-38-6
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
1-(4-Octylphenyl)ethanone
|
813-245-0
|
10541-56-7
|
|
Notified C&L
|
View details
|
Isoquinoline, 1,2,3,4-tetrahydro-1-phenyl-, (R)-
|
813-246-6
|
180272-45-1
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Diethyl 2-acetamido-2-[2-(4-octylphenyl)-2-oxo-ethyl] propanedioate
|
813-247-1
|
268557-49-9
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
Polyisoprene, trans
|
813-248-7
|
104389-32-4
|
|
Notified C&L
|
View details
|
dibutylcarbamodithioic acid
|
813-249-2
|
150-11-8
|
|
Notified C&L
|
View details
|
2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)fenyl]-3-(2,2,2-trifluoroacetylamino) propanamid
|
813-250-8
|
260980-89-0
|
Eye Irrit. 2
Aquatic Chronic 2
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
943-971-4
|
|
|
REACH registration C&L
|
View details
|
Reaction products of 6-hydroxy-5-nitrosonaphthalene-2-sulfonic acid, chelated with iron (3+), sodium salts.
|
943-973-5
|
|
|
REACH registration C&L
|
View details
|
2-Amino-4-chloro-6-ethylpyrimidine
|
813-251-3
|
5734-67-8
|
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
|
Notified C&L
|
View details
|
2H-1,4-Benzodiazepin-2-one, 3-(acetyloxy)-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-
|
813-253-4
|
96576-92-0
|
|
Notified C&L
|
View details
|
Piperazinium, 4-(3-aminopyrazolo[1,5-a]pyridin-2-yl)-1,1-dimethyl-, chloride, hydrochloride (1:1:2)
|
813-255-5
|
1256553-33-9
|
Acute Tox. 4
Aquatic Chronic 2
|
Notified C&L
|
View details
|
N1,N3-bis(2-sulfanylethyl)benzene-1,3-dicarboxamide
|
813-256-0
|
351994-94-0
|
|
Notified C&L
|
View details
|
Chloro(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II),
|
813-257-6
|
1451002-39-3
|
|
Notified C&L
|
View details
|
N-[Trans-4[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-Ethyl-5,6,7,8-Tetrahydro-5-Methyl-8-(1-Methylethyl)-6-Oxo-2-Pteridinyl]Amino]-3-Methoxy-Benzamide
|
813-258-1
|
755038-65-4
|
Acute Tox. 2
Skin Irrit. 2
Eye Irrit. 2
Repr. 2
STOT RE 2
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
[No public or meaningful name is available]
|
|
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Caesium hexafluorophosphate
|
813-259-7
|
16893-41-7
|
|
Notified C&L
|
View details
|
3-Chloro-1H-pyrazole
|
813-260-2
|
14339-33-4
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-BROMO-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE
|
813-261-8
|
1086064-49-4
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-Pentyl-1H-imidazole
|
813-262-3
|
19768-54-8
|
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
|
Notified C&L
|
View details
|
Esterification products of C10-14 (even numbered) alkyl oligomeric glycosides with citric acid, disodium salts
|
943-980-3
|
|
|
Notified C&L
|
View details
|
Conotoxin BruIB
|
943-981-9
|
|
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
|
Notified C&L
|
View details
|
(D-Lys(6-maleimido-hexanoyl)6)-Polymyxin B
|
943-982-4
|
|
|
Notified C&L
|
View details
|
(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream)
|
813-263-9
|
319429-24-8
|
|
Notified C&L
|
View details
|
9-(2-carboxy-3,4,5,6-tetrachlorophenyl)-3,6-bis(diethylamino)xanthylium perchlorate
|
943-984-5
|
|
Eye Dam. 1
Aquatic Chronic 3
|
Notified C&L
|
View details
|
(1R)-1-isopropyl-4-methyl-cyclohex-3-en-1-ol
|
943-985-0
|
20126-76-5
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
|
REACH registration C&L
|
View details
|
METHYL 4-(17-AMINO-28-NORLUPA-2,20(29)-DIEN-3-YL)BENZOATE
|
813-264-4
|
1392314-32-7
|
|
Notified C&L
|
View details
|
6-chlorohexyl 2-methylprop-2-enoate
|
813-266-5
|
45101-66-4
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
|
REACH registration C&L
|
View details
|
(2-chloro-4-(trifluoromethyl)phenyl)hydrazine
|
813-267-0
|
86398-98-3
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1,3,5-Benzenetricarboxylic acid, copper(2+) salt (2:3)
|
813-272-8
|
309721-49-1
|
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
|
|
|
|
|
|